-
Serum Institute to start manufacturing Sputnik vaccine in September
As part of the technology transfer process, SII has already received cell and vector samples from the Gamaleya Center.
-
Sputnik V will be available at govt vaccination sites soon
India has now four Covid-19 vaccines so far, including Bharat Biotech’s Covaxin and Serum-AstraZeneca’s Covishield
-
This newly listed firm doubled investors' money in 8 months
The company is an established player globally in sterile injectables and is one of the fastest-growing generic injectable companies
-
Sputnik V roll out delayed in Delhi
According to Gamaleya and the RDIF, Sputnik V has demonstrated an efficacy rate of 92 per cent
-
Sputnik V pilot in final leg, scaled up to other cities: Dr Reddy’s
Sputnik V Covid-19 vaccine updates: The limited pilot phase is currently in its final leg as we gear up to ensure a smooth commercial launch
-
Brazil clears import of Bharat Biotech’s Covaxin, Russia’s Sputnik V
According to Brazillian health regulator Anvisa, Brazil is expected to receive four million doses of Covaxin initially.
-
Serum Institute seeks test licence from DCGI to manufacture Covid vaccine Sputnik V
Russia's Sputnik V vaccine is currently being manufactured in India by Dr Reddy's Laboratories
-
Covid-19 Vaccine: Serum Institute seeks test licence from DCGI to manufacture Sputnik V
The Serum Institute of India (SII) has put up an application to the Drugs Controller General of India seeking permission for a test licence to manufac
-
Consignment of 3 million doses of Sputnik V vaccine from Russia land in Hyderabad
The Sputnik V vaccine requires specialised handling and storage, required to be kept at a temperature of -20 C.
-
Delhi likely to get Sputnik V in June: Arvind Kejriwal
Delhi CM Arvind Kejriwal also said the city currently has around 944 cases of mucormycosis or black fungus, including 300 at the central government-ru
